Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

AP/San Francisco Chronicle Examines Criticism That Gilead Has Not Done Enough To Make HIV/AIDS Drugs Available in Developing Nations

June 6, 2006

The AP/San Francisco Chronicle on Sunday examined how Gilead's success with its antiretroviral drug Truvada "hasn't insulated [the company] from complaints that it isn't doing enough to combat [HIV/AIDS] where it hits hardest," namely developing nations. According to the AP/Chronicle, Gilead "acknowledges" that it has a duty to make its drugs available to people in developing countries. The company about three years ago began the Gilead Access Program, which seeks to improve access to antiretroviral drugs in developing countries. However, some HIV/AIDS advocates say the program is an "empty promise," the AP/Chronicle reports (Elias, AP/San Francisco Chronicle, 6/4). The international aid organization Medecins Sans Frontieres in February said Gilead had not fulfilled its promise to provide its antiretroviral drug Viread at reduced costs to programs in developing nations (Kaiser Daily HIV/AIDS Report, 2/9). Gilead CEO John Martin said that the company must be given the opportunity to have its drugs approved by governments in developing countries. He added that Gilead believes in intellectual property rights worldwide. "We are one small company in a big world where billions of dollars are being put at the problem of AIDS," Martin said, adding, "On principal we believe that our product should be patented" (AP/San Francisco Chronicle, 6/4). Two HIV/AIDS advocacy groups in India last month filed an opposition application with the New Delhi patent office to oppose the company's application to patent Viread (Kaiser Daily HIV/AIDS Report, 5/12).

Back to other news for June 6, 2006


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2006 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement